The FDA has authorized the Pfizer-BioNTech COVID-19 Vaccine to be administered to children ages 5 to 11, giving pharmacists and technicians the opportunity to prove their value as immunizers.
Pharmacy Times conducted an interview with Anna Legreid Dopp, PharmD, CPHQ, senior director of clinical guidelines and quality improvement at the American Society of Health-System Pharmacist to talk about how the vaccine not only benefits children but also pharmacies and technicians. Watch to learn more!
For the source of information and more pharmacy news:
Comments